-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
April 01, 2014 - comorbidities in
this population, since many types of cancer and less
common comorbidities such as liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
March 01, 2015 - Spontaneous reports
of assumed herbal hepatotoxicity by black cohosh: is the liver-
unspecific Naranjo
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs015274-carayon-final-report-2009.pdf
January 01, 2009 - All CV surgery
patients and acute
MI/post
catheterization;
kidney, pancreas or
liver transplants
-
integrationacademy.ahrq.gov/products/topic-briefs/polysubstance-use
February 01, 2025 - Alcohol Use Disorders Identification Test - Alcoholic Liver Disease. Washington DC:U.S.
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs020909-dixon-final-report-2017.pdf
January 01, 2017 - only included test results data for a case
of hepatitis B but also corollary results on the patient's liver
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023952-chrischilles-final-report-2018.pdf
January 01, 2018 - significant hepatic disease
including cirrhosis, chronic hepatitis B or C, or have current elevated liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
January 01, 2010 - insulin secretion from the pancreatic beta cells; insulin action at the
level of skeletal muscle, liver
-
psnet.ahrq.gov/web-mm/framework-assessing-reasoning-about-controversial-end-life-clinical-decisions
November 30, 2023 - A framework for assessing reasoning about controversial end-of-life clinical decisions.
Citation Text:
Fedyk M, Fairman N, Romano PS, et al. A framework for assessing reasoning about controversial end-of-life clinical decisions.. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
November 22, 2011 - treatment (including bleeding events and other
adverse events such as gastrointestinal events and liver
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015339-aranaydo-final-report-2007.pdf
January 01, 2007 - example: a patient with
hepatitis has an automatic diagnosis alert on all meds metabolized by the liver
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017099-weiner-final-report-2010.pdf
January 01, 2010 - fatigue, miscellaneous disorders; and a group of more serious diagnoses, which included
categories for liver
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017067-kaushal-final-report-2011.pdf
January 01, 2011 - days)
Total cholesterol (6 weeks)
HDL cholesterol (6 weeks)
Thyroid stimulating hormone (6 weeks)
Liver
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/perinatal-care-2/hypertension_4-situation-monitoring-speaker-notes.pdf
July 01, 2023 - Smith, your labs just returned and are notable for an elevated
protein/creatinine ratio and elevated liver
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/xt2Uhv4qyLUZ8o2HB_a4YQ
July 01, 2013 - Longer-term use of
ART regimens may increase the risk for cardiovascular and
bone disease, as well as liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - systemic therapies are contraindicated or cannot be tolerated; prophylaxis of organ rejection in
kidney, liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
January 01, 2013 - For example, in
patients with end-stage liver disease, the natural history of disease is so well known
-
hcup-us.ahrq.gov/reports/methods/2006_1.pdf
January 01, 2006 - infarction, peptic ulcer
disease, congestive heart failure, cerebrovascular disease, hemiplegia, and severe liver
-
effectivehealthcare.ahrq.gov/health-topics/memory
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
February 01, 2015 - The reviews addressed four
topics: drug eluting stents, lung volume reduction surgery, living donor liver … For living donor liver transplantation, there was one rapid review; for the
remaining topics there were
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/_SBmXPhUQWo-dc85FJ5wHf
February 01, 2015 - Development of new fatty liver, or
resolution of existing fatty liver, over five years of follow-up,